Escalating Colistin Resistance in Carbapenem‐Resistant Klebsiella pneumoniae : Evidence of mcr‐1 and bla NDM Co‐Production
Biotechnology and Applied Biochemistry · 2025
DOI: 10.1002/bab.70069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Abdulmalik Yakubu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. Hauptthemen laut MEDLINE: Colistin, Klebsiella pneumoniae, beta-Lactamases, Bacterial Proteins. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Universiti Sains Malaysia.
Abstract (Originalsprache)
Carbapenem resistance among multidrug‐resistant pathogens is a growing global concern, particularly in Asia. The increased use of colistin as a final treatment option for carbapenem‐resistant Enterobacteriaceae has contributed to the development of colistin resistance. This study sought to identify the prevalence of carbapenemase and colistin resistance genes in carbapenem‐resistant Klebsiella pneumoniae (CRKP) isolates from a Malaysian tertiary hospital. A total of 257 different CRKP isolates were obtained from various clinical specimens between January 2017 and November 2020. Antibiotic susceptibility testing and multiplex polymerase chain reaction were performed to detect carbapenemase genes ( bla NDM , bla KPC , and bla OXA ) and the colistin resistance gene mcr‐1 . The bla NDM gene was found in 247 isolates (95.3%), bla OXA in one (0.4%), and mcr‐1 in two (0.8%). Two isolates co‐harbored bla NDM and mcr‐1 , whereas one had both bla NDM and bla OXA . No bla KPC gene was detected. The highest number of bla NDM ‐positive isolates came from endotracheal tubes specimens (21.8%). Males accounted for 65.7% of cases, with the highest prevalence in patients aged 61–80. Ertapenem showed the highest resistance (99.6%) among the carbapenems tested. This study highlights a high prevalence of bla NDM in CRKP and reports the first detection of mcr‐1 in this hospital. These findings underscore the urgent need for the judicious use of colistin in managing infections caused by CRKP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Department of Microbiology, Umaru Musa Yar'adua University, Katsina, Nigeria.
- Department of Medical Microbiology, School of Medical Science, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Infection Control Unit, Hospital Pakar Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Borneo Marine Research Institute, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.
ORCID-Profile: Siti Marwanis Anua, Siti Suraiya, Nik Mohd Noor Nik Zuraina, Nurzafirah Mazlan
Förderung
- Universiti Sains Malaysia
Zitieren
APA
Yakubu, A., Anua, S. M., Suraiya, S., Nik Zuraina, N. M. N., Mazlan, N., & Khairi, H. H. (2025). Escalating Colistin Resistance in Carbapenem‐Resistant Klebsiella pneumoniae : Evidence of mcr‐1 and bla NDM Co‐Production. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.70069
Vancouver
Yakubu A, Anua SM, Suraiya S, Nik Zuraina NMN, Mazlan N, Khairi HH. Escalating Colistin Resistance in Carbapenem‐Resistant Klebsiella pneumoniae : Evidence of mcr‐1 and bla NDM Co‐Production. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.70069
BibTeX
@article{Yakubu2025,
author = {Yakubu, Abdulmalik and Anua, Siti Marwanis and Suraiya, Siti and Nik Zuraina, Nik Mohd Noor and Mazlan, Nurzafirah and Khairi, Hazlam Hazim},
title = {Escalating Colistin Resistance in Carbapenem‐Resistant Klebsiella pneumoniae : Evidence of mcr‐1 and bla NDM Co‐Production},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
doi = {10.1002/bab.70069}
}
EUVIMED